TYK Medicines

company

About

It is an international innovative biotechnology high-tech company focuses on the research and development of new tumor drugs.

  • 11 - 50

Details

Last Funding Type
Series C
Last Funding Money Raised
¥330M
Industries
Biotechnology,Health Care,Product Research
Founded date
Jan 1, 2018
Number Of Employee
11 - 50
Operating Status
Active

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
¥330M
TYK Medicines has raised a total of ¥330M in funding over 2 rounds. Their latest funding was raised on Jan 7, 2022 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 7, 2022 Series C ¥330M 1 Houji Ziben Detail

Investors

Number of Lead Investors
Number of Investors
1
1
TYK Medicines is funded by 1 investors. Houji Ziben are the most recent investors.
Investor Name Lead Investor Funding Round
Houji Ziben Yes Series C